What is Aase Syndrome?

Aase syndrome is a very rare genetic condition characterized by two main features: anemia (a low number of red blood cells) and triphalangeal thumbs (thumbs that have three bones instead of the usual two, making them look more like fingers). The condition is also sometimes called Aase-Smith syndrome.

The anemia in Aase syndrome is a specific type called hypoplastic anemia, which means the bone marrow (the spongy tissue inside bones that makes blood cells) does not produce enough red blood cells. Red blood cells carry oxygen throughout the body, so low levels can cause fatigue, paleness, and difficulty breathing.

The condition was first described by pediatricians Jon Morton Aase and David Weyhe Smith in 1969. Because of overlapping features with another condition called Diamond-Blackfan anemia, some experts debate whether Aase syndrome is a truly separate disorder or a variant of that condition.

What is the prevalence of Aase Syndrome?

Aase syndrome is extremely rare. Only a small number of cases have been reported in the medical literature worldwide, and the exact prevalence is not known. Because it is so rare, it is difficult to estimate how often the condition occurs in the general population.

The condition appears to affect males and females in roughly equal numbers. Due to its rarity, much of the medical understanding comes from individual case reports rather than large studies.

How is Aase Syndrome diagnosed?

Diagnosis of Aase syndrome is based on clinical findings — mainly the combination of congenital (present at birth) hypoplastic anemia and triphalangeal thumbs. A blood test showing low red blood cell production, along with a physical examination showing the characteristic thumb shape, forms the basis for diagnosis.

Bone marrow examination (a procedure where a small sample of marrow is tested) may be used to confirm that the bone marrow is not making enough red blood cells. Imaging, such as X-rays, can confirm the three-bone structure of the thumbs.

Genetic testing may be considered to look for variants associated with related conditions like Diamond-Blackfan anemia, which shares several features. A hematologist (blood specialist) and a clinical geneticist are typically involved in diagnosis.

Is there any specific gene or pathway in Aase Syndrome that has been identified?

The exact genetic cause of Aase syndrome as a distinct condition has not been definitively established. Because of its close resemblance to Diamond-Blackfan anemia, researchers have looked at genes involved in ribosome (the cell's protein-making machinery) function, particularly ribosomal protein genes such as RPS19. However, a clear and consistent genetic cause unique to Aase syndrome has not been confirmed.

The condition is thought to be inherited in an autosomal dominant pattern, meaning a change in one copy of the relevant gene may be sufficient to cause the condition. However, the genetic picture remains incompletely understood due to the very small number of reported cases.

This area is still under investigation, and advances in genetic sequencing technology may help clarify the molecular basis of Aase syndrome in the future.

How is Aase Syndrome treated?

Treatment focuses on managing the anemia. In some cases, the anemia improves on its own as the child grows older. When treatment is needed, corticosteroids (medications that reduce inflammation and can stimulate blood cell production) have been used.

Blood transfusions may be given to raise red blood cell levels in severe cases. In some individuals, the anemia has been treated with approaches similar to those used in Diamond-Blackfan anemia, such as steroid therapy. Bone marrow transplantation (replacing damaged marrow with healthy marrow from a donor) has been used in some severe cases of related anemia conditions.

The triphalangeal thumbs do not usually require treatment unless they cause functional problems, in which case surgical options may be considered. Regular follow-up with a hematologist is important for monitoring blood cell counts.

Are there any clinical trials underway for Aase Syndrome?

Because Aase syndrome is so rare, dedicated clinical trials specifically for this condition are not known to exist. Clinical trial counts for Aase syndrome could not be verified from available sources at the time this page was prepared.

Research on Diamond-Blackfan anemia, a closely related condition, is more active and may offer relevant insights. Individuals and families may wish to consult with a specialist at an academic medical center or rare disease center to learn about any applicable research opportunities. Searching ClinicalTrials.gov for related bone marrow failure conditions may also be useful.

How can RareShare be helpful to Aase Syndrome patients and families?

RareShare can help people affected by Aase syndrome connect with other patients, caregivers, and families, share lived experiences, and learn about community resources. Current RareShare community statistics could not be verified. These discussions can support connection, education, and ongoing access to shared experiences and resources.